Log in
Products & Solutions
Who we serve
Contact
Log in
Request trial & quote
Menu
Menu
Skip navigation
Home
Log in Biotechgate
Search website
Products & Solutions
Assets & out-licensing
Clinical trials
Companies and management
Benchmark license agreements
Investor Database
Biotechgate Digital Partnering
Data sourcing and features
Who we serve
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Life Science Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Log in
Request trial & quote
Menu
Menu
Skip navigation
Home
Log in Biotechgate
Search website
Products & Solutions
Assets & out-licensing
Clinical trials
Companies and management
Benchmark license agreements
Investor Database
Biotechgate Digital Partnering
Data sourcing and features
Who we serve
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Life Science Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Log in
Request trial & quote
Menu
Menu
Skip navigation
Home
Log in Biotechgate
Search website
Products & Solutions
Assets & out-licensing
Clinical trials
Companies and management
Benchmark license agreements
Investor Database
Biotechgate Digital Partnering
Data sourcing and features
Who we serve
Big Pharma
Biotech & Medtech
CRO & CMO
Investors
Consulting & Services
Government Agencies and Industry Associations
Reports & Downloads
Biotech Financing Report
Life Science Trend Analysis
Resource Center
Industry News
Life Science Company News
Conferences
About
Who we are
Our Partners
Countries Covered
Industry Sectors Covered
Add your company
Terms of use
Contact
Life Science Company News
Back to overview
Reduction of share capital
Please read the full announcement in PDF
Attachment
2020_20_Reduction_of_shares_capital_EN
By:
GlobeNewswire
- 27 Mar 2020
Back to overview
Enhance your business development with Biotechgate
Try for free »
